,9 After treatment with erlotinib, a first-generation EGFR TKI, 1 patient experienced fever, erythematous patches, and butterfly-shaped erythema over the cheeks consistent with a systemic lupus erythematosus-like reaction.8 This evidence concerns the gene EGFR and systemic lupus erythematosus.